Indomo Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$25M
- Investors
-
11
Indomo General Information
Description
Developer of acne care therapeutics intended to offer device-enabled innovations for acne care. The company offers an acne drug paired with a novel intradermal self-injection device for the resolution of moderate to severe acne lesions, allowing patients to access intralesional acne injections whenever and wherever they need them.
Contact Information
Website
www.indomotx.comCorporate Office
- 1 Letterman Drive
- Suite C3500
- San Francisco, CA 94129
- United States
Corporate Office
- 1 Letterman Drive
- Suite C3500
- San Francisco, CA 94129
- United States
Indomo Timeline
Indomo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 27-May-2025 | $25M | Completed | Pre-Clinical Trials | ||
| 3. Early Stage VC (Series A1) | 21-Aug-2023 | Completed | Stealth | |||
| 2. Accelerator/Incubator | 01-Jul-2023 | $120K | $760K | Completed | Stealth | |
| 1. Early Stage VC (Series A2) | 11-Oct-2022 | $640K | $640K | Completed | Stealth |
Indomo Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A-2 | 38,837,830 | $0.000001 | $0.02 | $0.02 | 1x | $0.02 | 7.76% | |
| Series A-1 | 129,218,582 | $0.000001 | $0.08 | $0.08 | 1x | $0.08 | 25.81% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Indomo Patents
Indomo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026218024-A1 | Systems and devices for controlled fluid injection | Pending | 11-Apr-2025 | ||
| AU-2022349691-A1 | Systems, devices and methods for dermal treatments | Pending | 24-Sep-2021 | ||
| CA-3232828-A1 | Systems, devices and methods for dermal treatments | Pending | 24-Sep-2021 | ||
| EP-4404829-A1 | Systems, devices and methods for dermal treatments | Pending | 24-Sep-2021 | ||
| EP-4404829-A4 | Systems, devices and methods for dermal treatments | Pending | 24-Sep-2021 | A61B5/4839 |
Indomo Signals
Indomo Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Foresite Capital | Growth/Expansion | Minority | ||
| Atomic14 Ventures | Venture Capital | Minority | ||
| Atomic (Private Equity) | Venture Capital | Minority | ||
| Evolution VC Partners | Venture Capital | Minority | ||
| FORM Life Ventures | Venture Capital | Minority |
Indomo FAQs
-
When was Indomo founded?
Indomo was founded in 2021.
-
Where is Indomo headquartered?
Indomo is headquartered in San Francisco, CA.
-
What is the size of Indomo?
Indomo has 7 total employees.
-
What industry is Indomo in?
Indomo’s primary industry is Drug Delivery.
-
Is Indomo a private or public company?
Indomo is a Private company.
-
What is the current valuation of Indomo?
The current valuation of Indomo is .
-
What is Indomo’s current revenue?
The current revenue for Indomo is .
-
How much funding has Indomo raised over time?
Indomo has raised $42.2M.
-
Who are Indomo’s investors?
Foresite Capital, Atomic14 Ventures, Atomic (Private Equity), Evolution VC Partners, and FORM Life Ventures are 5 of 11 investors who have invested in Indomo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process